tamoxifen citrate
PolandDrugs containing this active substance
-
This medicine is intended for the treatment of breast cancer.
Form: tablets
Active substance Dosage tamoxifen citrate 30.4 mg ATC: L02BA01
Manufacturer: Egis Pharmaceuticals PLC
-
The medicine is used to treat advanced breast cancer with metastases or as adjuvant therapy following primary treatment of this cancer.
Form: tablets, film-coated
Active substance Dosage tamoxifen citrate 20 mg ATC: L02BA01
Manufacturer: Salutas Pharma GmbH
-
The medicinal product is used for the treatment of breast cancer. It may be administered alone or in combination with other anticancer drugs.
Form: tablets
Active substance Dosage tamoxifen citrate 15.2 mg ATC: L02BA01
Manufacturer: Ebewe Pharma GmbH Nfg. KG, Lek Pharmaceuticals d.d., Salutas Pharma GmbH